Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) EPS (Basic) : ¥-0.24 (TTM As of Sep. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co EPS (Basic)?

Zhejiang Hisoar Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ¥-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.24.

Zhejiang Hisoar Pharmaceutical Co's EPS (Diluted) for the three months ended in Sep. 2024 was ¥-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.24.

Zhejiang Hisoar Pharmaceutical Co's EPS without NRI for the three months ended in Sep. 2024 was ¥-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.22.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zhejiang Hisoar Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 227.10% per year. The lowest was -52.80% per year. And the median was -9.25% per year.

Zhejiang Hisoar Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co EPS (Basic) Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.48

0.20

0.06

0.05

-0.26

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															-0.03	-0.24	0.02	-	-0.02

Zhejiang Hisoar Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zhejiang Hisoar Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-420.056	-	0)	/	1615.599
	=	-0.26

Zhejiang Hisoar Pharmaceutical Co's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-26.123	-	0)	/	1197.976
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.24

Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Zhejiang Hisoar Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Hisoar Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000

Website

http://www.hisoar.com

Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.

Executives

Wang Yang Chao	Director
Yang Si Wei	Directors, executives
Xu Guo Rui	Executives
Xu Hua Qing	Secretary Dong
Hong Ming	Director
Guo Min Long	Director
Li Hong Ming	Executives
Jiang Ru Dong	Securities Affairs Representative
Mao Wen Hua	Executives
Sun Yang	Director
Li Wei Jin	Director
Luo Yu Hong	Director
Pan Qing Hua	Directors, executives
Chen Zheng Hua	Supervisors
Jia Qiang	Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines